Statistics
Publications
37
Citations
6.4K
H-Index
28
Active since
1999
Mary Keir is an author at Harvard University specializing in immunology, life sciences, and inflammation.
Publications per year
1999–2025
37
37
Tissue expression of PD-L1 mediates peripheral T cell tolerance
Mary Keir, Spencer C. Liang, Indira Guleria et al. · The Journal of Experimental Medicine · 2006 · 1.2K citations · Full text
Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial
Séverine Vermeire, Sharon O’Byrne, Mary Keir et al. · The Lancet · 2014 · 453 citations · Full text
1–5 of 37